Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance

Take a look inside the London 2014 Congress


Then register to join us
in Barcelona!

Initial commercial experience and clinical outcomes with presbyopia correcting hydrogel corneal inlay

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Intracorneal Inlays for Presbyopia

Session Date/Time: Tuesday 08/09/2015 | 16:00-18:00

Paper Time: 16:54

Venue: Main Auditorium

First Author: : M.Zahorcova SLOVAKIA

Co Author(s): :    L. Valesova                    

Abstract Details


To report our experiences and clinical outcomes with Raindrop Near Vision Inlay (ReVision Optics, Inc., Lake Forest, CA) in a chain of multicenter commercial clinics in Central Europe.


NeoVizia Bratislava, Slovakia, DuoVize Prague and NeoVize Brno, Czech Republic.


52 presbyopic patients were implanted unilaterally in the non-dominant eye with the hydrogel corneal inlay under a flap created by femtosecond laser and centered over the light constricted pupil. Manifest refraction, patient satisfaction, and visual acuities at distance and near were collected at 1 day, 1 week, 1 month and 3 months after surgery.


Mean age was 50 years (range: 45-60) with pre-operative mean MRSE of +0.48 D. At 1 month, 98% of patients (n=51) achieved binocular uncorrected distance vision of 1.0 or better, and 88% of patients (n=48) achieved binocular uncorrected near vision 0.8 or better. At 3 months, the mean sphere is -0.78 D and the mean cylinder is -0.69 D. Fifty patients (97%) were either ‘'Satisfied or Very Satisfied'' with the procedure. Complications were low with one case of corneal complications (mild striae, edema) and one case of decentration that required recentering. All complications resolved by 3 months.


Raindrop Near Vision Inlay outcomes were very consistent between clinics with near improvement of 0.8 or better. Low complication and high satisfaction rates make this inlay in short-term follow-up a reliable option in treating presbyopia in our practice.

Financial Interest:

One of the authors travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to previous